140 related articles for article (PubMed ID: 2424305)
1. Procainamide toxicity in a patient with acute renal failure.
Rosansky SJ; Brady ME
Am J Kidney Dis; 1986 Jun; 7(6):502-6. PubMed ID: 2424305
[TBL] [Abstract][Full Text] [Related]
2. Resin hemoperfusion for severe N-acetylprocainamide toxicity in patients with renal failure.
Raja R; Kramer M; Alvis R; Goldstein S; DeLosAngeles A
Trans Am Soc Artif Intern Organs; 1984; 30():18-20. PubMed ID: 6085435
[No Abstract] [Full Text] [Related]
3. Hemoperfusion for treatment of N-acetylprocainamide intoxication.
Braden GL; Fitzgibbons JP; Germain MJ; Ledewitz HM
Ann Intern Med; 1986 Jul; 105(1):64-5. PubMed ID: 2424355
[No Abstract] [Full Text] [Related]
4. Combined high-efficiency hemodialysis and charcoal hemoperfusion in severe N-acetylprocainamide intoxication.
Kar PM; Kellner K; Ing TS; Leehey DJ
Am J Kidney Dis; 1992 Oct; 20(4):403-6. PubMed ID: 1384320
[TBL] [Abstract][Full Text] [Related]
5. Removal of toxic levels of N-acetylprocainamide with continuous arteriovenous hemofiltration or continuous arteriovenous hemodiafiltration.
Domoto DT; Brown WW; Bruggensmith P
Ann Intern Med; 1987 Apr; 106(4):550-2. PubMed ID: 2435200
[TBL] [Abstract][Full Text] [Related]
6. Transport of procainamide and N-acetylprocainamide from blood into the intestinal lumen and intestinal dialysis by oral activated charcoal in rats with acute renal failure.
Arimori K; Nakano M
J Pharmacobiodyn; 1988 Jul; 11(7):504-11. PubMed ID: 2460613
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.
Roden DM; Reele SB; Higgins SB; Wilkinson GR; Smith RF; Oates JA; Woosley RL
Am J Cardiol; 1980 Sep; 46(3):463-8. PubMed ID: 6158263
[TBL] [Abstract][Full Text] [Related]
8. Relative efficacy of haemoperfusion, haemodialysis and CAPD in the removal of procainamide and NAPA in a patient with severe procainamide toxicity.
Low CL; Phelps KR; Bailie GR
Nephrol Dial Transplant; 1996 May; 11(5):881-4. PubMed ID: 8671917
[No Abstract] [Full Text] [Related]
9. Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function.
Drayer DE; Lowenthal DT; Woosley RL; Nies AS; Schwartz A; Reidenberg MM
Clin Pharmacol Ther; 1977 Jul; 22(1):63-9. PubMed ID: 872496
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the pharmacokinetic and pharmacodynamic properties of procainamide and N-acetylprocainamide.
Atkinson AJ; Ruo TI; Piergies AA
Angiology; 1988 Jul; 39(7 Pt 2):655-67. PubMed ID: 2457345
[TBL] [Abstract][Full Text] [Related]
11. Influence of age, renal function and heart failure on procainamide clearance and n-acetylprocainamide serum concentrations.
Bauer LA; Black D; Gensler A; Sprinkle J
Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):213-6. PubMed ID: 2472362
[TBL] [Abstract][Full Text] [Related]
12. Use of procainamide in chronic ambulatory peritoneal dialysis: report of a case.
Kroboth PD; Mitchum K; Puschett JB
Am J Kidney Dis; 1984 Jul; 4(1):78-9. PubMed ID: 6204527
[TBL] [Abstract][Full Text] [Related]
13. N-acetylprocainamide toxicity.
Mitnick PD
Ann Intern Med; 1987 Sep; 107(3):424-5. PubMed ID: 2441636
[No Abstract] [Full Text] [Related]
14. Torsade de pointes induced by N-acetylprocainamide.
Chow MJ; Piergies AA; Bowsher DJ; Murphy JJ; Kushner W; Ruo TI; Asada A; Talano JV; Atkinson AJ
J Am Coll Cardiol; 1984 Sep; 4(3):621-4. PubMed ID: 6206104
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humans.
Funck-Brentano C; Light RT; Lineberry MD; Wright GM; Roden DM; Woosley RL
J Cardiovasc Pharmacol; 1989 Sep; 14(3):364-73. PubMed ID: 2476614
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of N-acetylprocainamide in long-term treatment of ventricular arrhythmias.
Atkinson AJ; Lertora JJ; Kushner W; Chao GC; Nevin MJ
Clin Pharmacol Ther; 1983 May; 33(5):565-76. PubMed ID: 6188570
[TBL] [Abstract][Full Text] [Related]
17. Hemoperfusion for N-acetylprocainamide intoxication.
Borkan SC
Ann Intern Med; 1986 Dec; 105(6):965-6. PubMed ID: 2430494
[No Abstract] [Full Text] [Related]
18. Pharmacokinetics of procainamide in continuous ambulatory peritoneal dialysis.
Sica DA; Yonce C; Small R; Cefali E; Harford A; Poynor W
Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):59-64. PubMed ID: 2457560
[TBL] [Abstract][Full Text] [Related]
19. [Steady-state plasma and saliva concentrations of procainamide and N-acetyl-procainamide after a sustained release preparation].
Pirovino M; Karlaganis G; Galeazzi RL
Schweiz Med Wochenschr; 1980 Sep; 110(39):1415-9. PubMed ID: 6169144
[TBL] [Abstract][Full Text] [Related]
20. Torsades de pointes due to n-acetylprocainamide.
Stevenson WG; Weiss J
Pacing Clin Electrophysiol; 1985 Jul; 8(4):528-31. PubMed ID: 2410877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
